|
|
|
Volumn 5, Issue 12, 2004, Pages 1298-1310
|
|
Histamine dihydrochloride (subcutaneous) maxim
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ALPHA INTERFERON;
CYTOKINE;
DACARBAZINE;
EPILEUKIN;
HISTAMINE;
HISTAMINE H2 RECEPTOR AGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
INTERLEUKIN 2;
MAXAMINE;
MAXDERM;
MELPHALAN;
PEGINTERFERON;
RANITIDINE;
RIBAVIRIN;
SEROTONIN 1A AGONIST;
ACUTE GRANULOCYTIC LEUKEMIA;
ADJUVANT THERAPY;
ALCOHOL LIVER DISEASE;
AREA UNDER THE CURVE;
AUSTRALIA;
BURN;
CANADA;
CANCER ADJUVANT THERAPY;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONJUNCTIVITIS;
COUGHING;
DECUBITUS;
DISEASE EXACERBATION;
DIZZINESS;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG ELIMINATION;
DRUG FEVER;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG ISOLATION;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
DYSPNEA;
ERYTHEMA;
EUROPE;
FATIGUE;
FLUSHING;
HEADACHE;
HEART PALPITATION;
HEPATITIS C;
HERPES LABIALIS;
HERPES ZOSTER;
HUMAN;
HYPOTENSION;
INJECTION SITE REACTION;
ISRAEL;
KIDNEY CARCINOMA;
LETHARGY;
LOW DRUG DOSE;
MELANOMA;
MUCOSA INFLAMMATION;
MUSCLE CRAMP;
NAUSEA;
NONHUMAN;
PATENT;
PROSTATE ADENOCARCINOMA;
RETINITIS;
REVIEW;
RIGOR;
SIDE EFFECT;
STOMATITIS;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTOPENIA;
UNITED STATES;
VASODILATATION;
VOMITING;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUGS, INVESTIGATIONAL;
HISTAMINE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
|
|
EID: 11344282398
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|
